IARPG-OPS-1 online Intelligence operations standard Fictional missions · neutral authorities

Research archive / Mental health and representation research

Psychotic Disorder Due to Another Medical Condition: Espionage Delusions

Diagnostic criteria (DSM-5-TR, ICD-11): Both DSM-5-TR and ICD-11 recognize psychosis caused by a medical condition. DSM-5-TR calls this Psychotic Disorder Due to Another Medical Condition, requiring prominent hallucinations or delusions and “evidence from the history, physical exam, or laboratory findings that the disturbance is the direct physiological consequence of a general medical condition.” The symptoms must…

Psychotic Disorder Due to Another Medical Condition: Espionage Delusions

Diagnostic criteria (DSM-5-TR, ICD-11): Both DSM-5-TR and ICD-11 recognize psychosis caused by a medical condition. DSM-5-TR calls this Psychotic Disorder Due to Another Medical Condition, requiring prominent hallucinations or delusions and “evidence from the history, physical exam, or laboratory findings that the disturbance is the direct physiological consequence of a general medical condition.” The symptoms must not be better explained by another mental disorder, must not occur only during delirium, and must cause significant impairment. ICD-11 similarly defines Secondary Psychotic Syndrome (code 6E61) as prominent hallucinations or delusions judged to be a direct pathophysiological consequence of a health condition, based on evidence from history, exam or labs; it excludes cases explained by delirium, other mental disorders, or psychological reactions. In practice, these criteria demand a clear temporal and causal link between a medical disorder and the psychosis, and exclusion of primary psychiatric or substance-induced causes.

Attributing psychosis to a medical cause: Establishing secondary (organic) psychosis requires demonstrating that the symptoms coincide with a medical or neurological illness. Clinicians look for a clear timeline (onset of psychosis concurrent with the medical condition) and objective evidence (lab tests, imaging or physical findings) implicating that condition. For example, discovery of a brain lesion or metabolic derangement in the context of new-onset psychosis shifts the diagnosis. DSM-5-TR specifies that the psychotic disturbance must be “the direct physiological consequence” of the condition. In contrast, delirium is a broader acute confusional syndrome (with inattention, fluctuating consciousness and cognitive change) that often causes hallucinations; DSM-5-TR explicitly disallows a psychotic disorder due to medical condition if the symptoms occur exclusively during delirium. In practice, a secondary psychosis diagnosis is only made after ruling out delirium and ensuring the psychosis persists apart from any waxing-and-waning sensorium.

Medical and neurological causes: Many conditions can underlie a secondary psychosis. Notable neurological causes include strokes, traumatic brain injury, multiple sclerosis, Parkinson’s or Huntington’s disease, and especially brain tumors or masses. For instance, frontal or temporal lobe tumors can present first with delusions or hallucinations. Seizure disorders, particularly temporal lobe epilepsy, can induce psychosis during ictal, postictal or interictal phases. In autoimmune/ inflammatory disorders, systemic lupus erythematosus and Hashimoto encephalopathy are classic causes – lupus cerebritis can provoke paranoia or hallucinations unrelated to steroid treatment. Paraneoplastic syndromes (e.g. anti-NMDA-receptor encephalitis, often with ovarian tumors) also cause severe delusions, sometimes accompanied by seizures or autonomic instability. Endocrine/metabolic causes include Cushing’s or Addison’s disease, thyroid storm or myxedema, pheochromocytoma, and hypoglycemia, all of which can trigger psychotic or delirium-like states. Infectious causes encompass HIV, neurosyphilis, Lyme disease and CNS infections (HSV encephalitis, etc.). Metabolic or nutritional disorders like hepatic or renal failure, acute intermittent porphyria, B12 or thiamine deficiency, and Wilson’s disease are also implicated. Finally, iatrogenic causes (medications, withdrawal) and substances must be considered, though they fall under separate DSM categories. In sum, the workup should consider CNS lesions, infections, systemic autoimmune or metabolic illnesses, endocrine dysfunctions, and other systemic diseases as potential sources of psychosis.

Warning signs (“red flags”): Certain clinical clues raise suspicion of a medical cause. Psychosis beginning late in life (e.g. >40–50 years old with no psychiatric history) or with an abrupt onset suggests organic pathology. Fluctuating mental status or disorientation (impaired orientation, attention, or memory) points toward delirium or encephalopathy. Neurological signs – new focal deficits, seizures or movement abnormalities (e.g. tremors, rigidity, myoclonus) – strongly indicate an underlying brain lesion or epilepsy. Systemic signs – high fever, tachycardia, unstable blood pressure or other autonomic changes – suggest metabolic or endocrine crises (e.g. thyroid storm, adrenal storm). Visual hallucinations (as opposed to purely auditory) are more common in organic disorders. A rapidly progressive course or cognitive decline, and poor response to antipsychotics, are also concerning for nonpsychiatric illness. In elderly patients, delirium is especially common; indeed, psychosis in an older adult is often a manifestation of delirium until proven otherwise. In summary, any of: age out of the typical schizophrenia range, acute or fluctuating course, abnormal vital signs or lab values, focal/neurogenic symptoms, or seizures, should prompt a thorough medical evaluation.

Differential Diagnosis: Distinguishing a secondary psychosis from other causes is critical. Delirium vs. secondary psychosis: delirium is an acute encephalopathy with inattention, fluctuating consciousness, disorientation and often hallucinations; by definition it is due to a medical cause, so one would diagnose delirium rather than a separate psychotic disorder. Major neurocognitive disorder (dementia) can include psychotic features, but dementia progresses insidiously with global cognitive decline (memory, executive, language deficits) over months or years; if the cognitive impairment is longstanding and progressive, a dementia diagnosis takes precedence. Substance- or medication-induced psychosis is diagnosed when psychosis clearly follows intoxication or withdrawal (e.g. amphetamines, alcohol, steroids). By contrast, psychosis “due to medical condition” requires showing that the disease itself (not a drug) is the culprit. Primary psychiatric disorders (schizophrenia, schizoaffective, bipolar, delusional disorder, etc.) typically have prodromal symptoms, family history, and an onset in adolescence or early adulthood. For example, chronic paranoid schizophrenia usually starts by the 30s and lacks obvious medical findings, whereas a middle-aged patient with fever and new onset paranoia likely has an organic cause. DSM-5-TR explicitly excludes a medical-condition psychosis if another mental disorder (primary or substance-related) better explains the symptoms. In practice, clinicians must rule out delirium and major neurocognitive disorder first, then consider whether medication or drug use might explain the psychosis, before labeling it “due to a medical condition.”

Evaluation and workup: All patients with first-onset psychosis merit a careful history and physical exam, including neurologic and mental-status exams. Vital signs and glucose should be checked immediately to exclude delirium causes. A basic laboratory screen is often performed (e.g. CBC, electrolytes, BUN/Cr, liver enzymes, calcium) to catch metabolic derangements. Specific tests tailored to clinical suspicion should follow. For example, thyroid function tests (TSH, free T4) are routine; if Cushing or Addison is suspected, cortisol (AM cortisol, dexamethasone test) and electrolytes are done. Syphilis serology (RPR/FTA) and HIV tests are standard because these infections are treatable causes of psychosis. Autoimmune screening (ANA, anti-thyroid antibodies, or paraneoplastic panels like anti-NMDA receptor antibodies) may be indicated if lupus or autoimmune encephalitis is in the differential. Vitamin levels (B12, folate, thiamine) and other metabolic tests (ammonia, porphyrins) may be considered for nutritional/metabolic disorders. A urine drug screen and medication review should be done to exclude intoxication or withdrawal. Imaging is guided by neurologic findings: an MRI of the brain is indicated if there are focal deficits, seizures, or atypical symptoms (many clinicians also obtain MRI in older patients with new psychosis). An electroencephalogram (EEG) is warranted if seizures or encephalopathy are suspected. If there is concern for CNS infection or autoimmune encephalitis, lumbar puncture is performed (with CSF cell count, glucose/protein, HSV PCR, oligoclonal bands, etc.). Importantly, there is no “one-size-fits-all” test panel; workup should be driven by the patient’s age, history, exam and local guidelines. Some guidelines emphasize that many routine tests have low yield without clues, so judicious, clue-driven testing is most efficient. Consultation with neurology, rheumatology or infectious disease may be needed based on findings.

Illness narrative (“architecture of persecution”): Persecutory delusions often incorporate real environmental details into a paranoid framework. For example, hospital devices and routines – telemetry leads, IV drips, wristbands, or overhead announcements – may be misinterpreted as high-tech spying. A deluded patient might believe an ECG electrode is a microphone, or that routine blood pressure cuffs are scanners extracting data. In effect, the clinical setting and equipment form the “architecture” on which the mind builds a persecution narrative. This is especially likely if the patient has cognitive impairment or delirium: novelty and complexity of a hospital ward can seem threatening and secretive. Clinicians should recognize that such beliefs are symptomatic, not evidence of actual monitoring or conspiracy, and should gently reorient the patient (“We check your blood pressure to make sure your heart is strong”) rather than challenge the content directly. Ultimately, these delusions reflect the illness, not reality; no medical or government plot is confirmed.

Treatment and follow-up: Management focuses on treating the underlying condition, with psychiatric care as needed. Whenever possible, reverse or mitigate the medical cause: for example, resect a brain tumor, normalize thyroid levels, treat infections (e.g. antibiotics for neurosyphilis), give immunotherapy for autoimmune encephalitis, or correct metabolic disturbances. As the primary illness is addressed, the psychotic symptoms often improve. Meanwhile, short-term antipsychotic medication may be used for severe agitation or dangerous delusions (choosing agents with caution given any underlying condition). For example, corticosteroids can worsen delirium, so alternative treatments are preferred if steroids must be used (as in Hashimoto encephalopathy). In anti-NMDA encephalitis, antipsychotics and benzodiazepines are used until immunotherapy takes effect. Movement abnormalities may need symptomatic treatment (e.g. propranolol for akathisia or tremors).

A critical task is to assess decisional capacity. Psychosis can impair a patient’s ability to understand and reason about treatment. Formal capacity testing (e.g. using the MacCAT-T) is often warranted if the patient refuses recommended interventions. If the patient lacks capacity, a surrogate decision-maker (often next-of-kin) may consent to treatment based on substituted judgment. Clinicians should document any impairment in insight or judgment and involve psychiatry or ethics consultants as needed. Family communication is essential: explain that the patient’s beliefs (e.g. about being spied on) are symptoms of illness, not truths, and update the family on medical findings and plans. Engaging family in care (with appropriate consent) helps ensure the patient’s values are honored and that the family can support treatment adherence.

Importance of thorough evaluation: It is hazardous to prematurely label a first-episode psychosis as “schizophrenia” without ruling out secondary causes. Misdiagnosis can deny patients treatment for reversible conditions and expose them to unnecessary psychotropics. For instance, cases of brain tumors, autoimmune encephalitis or severe endocrine imbalances have been mistaken for schizophrenia, delaying proper therapy. In contrast, identifying an organic cause can be lifesaving (e.g. treating neurosyphilis or removing a tumor). Evidence-based guidelines therefore emphasize ruling out medical mimics first, even if initial presentation looks psychiatric.

Case vignette: A 72-year-old retired intelligence analyst with no psychiatric history is admitted with a 2-week history of paranoia. He believes hospital staff and government agents have implanted a device in his arm that “feeds my thoughts to a spy satellite.” He is agitated, repeatedly trying to remove his IV line. Vital signs show hypertension and mild tachycardia. On exam, he has a subtle right arm weakness. Cognitive testing reveals mild disorientation. Because of his age and acute onset, a medical workup is done. Basic labs show slight hyponatremia and low TSH (suggesting thyroid dysfunction). Brain MRI reveals a left frontal meningioma encroaching on adjacent cortex. Lumbar puncture is unremarkable, and toxicology is negative. Initially, he was started on low-dose risperidone with minimal change. After endocrine evaluation suggests hyperthyroidism, he is given antithyroid medication and beta-blockers. Neurosurgery is consulted for the tumor. Over the next week, his blood pressure normalizes and the delusion gradually lessens. After surgical resection of the meningioma, he becomes oriented and the espionage beliefs resolve. The treatment focus shifts from long-term antipsychotics to managing thyroid levels and neurologic recovery, with family education about how his symptoms were due to medical illness rather than actual surveillance.

Sources: Authoritative psychiatric and medical sources were used throughout. DSM-5-TR criteria are summarized from APA guidance; ICD-11 definitions from WHO’s coding manual. Reviews and textbooks on secondary psychosis, including the Merck Manual and recent literature, provide evidence on causes, red flags, and management. These sources confirm that new-onset persecutory delusions should prompt medical evaluation and illustrate how identifying an organic etiology alters the diagnosis and treatment.

Connected tools and standards

Explore the wider AI ecosystem.